Cocrystal Pharma, Inc. (NASDAQ:COCP)
About the company
Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections. The company was founded on January 2, 2014 and is headquartered in Bothell, WA.
Gross Margin (in %)
Operating Margin (in %)
Net Margin (in %)
Dividend Yield (in %)
|Name||Ticker||Market capitalization (in USD Million)||Revenues (in USD Million)||Price/Book||Price/Earning||Net margin (in %)|
|BridgeBio Pharma, Inc.||BBIO||3590.07||41.00||9.45||-12.36||-718.08|
|Taro Pharmaceutical Industries Ltd.||TARO||2591.60||645.00||1.24||10.74||37.88|
|Abeona Therapeutics, Inc.||ABEO||210.80||3.00||2.15||-2.07||75.95|
|Kindred Biosciences, Inc.||KIN||150.93||4.00||2.51||-2.21||None|
|Cocrystal Pharma, Inc.||COCP||53.55||2.00||1.96||-0.92||-733.84|
|China Pharma Holdings, Inc.||CPHI||26.40||10.00||3.16||-1.22||-214.63|
|Jaguar Health, Inc.||JAGX||4.86||5.00||3.60||0.07||-887.14|
Latest insider transactions
|Date||Role||Name||Transaction||Quantity||Quantity Owned After|
COCRYSTAL PHARMA INC - ON JUNE 22, BOARD APPROVED INCREASE IN ANNUAL BASE SALARY OF CEO FROM $200,000 TO $315,000 * COCRYSTAL PHARMA INC - BOARD APPROVED INCREASE IN ANNUAL BASE SALARY OF PRESIDENT ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Lifshitz & Miller LLP Announces Investigation of Adient PLC, Applied Optoelectronics, Inc., Cocrystal Pharma, Inc., Microchip T
Before it's here, it's on the Bloomberg Terminal.
July 1 (Reuters) - Cocrystal Pharma Inc: * COCRYSTAL PHARMA INC - MAY OFFER, SELL SHARES OF COMMON STOCK HAVING AGGREGATE OFFERING PRICE OF UP TO $10 MILLION FROM TIME TO TIME Source text (bit.ly ...
Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is exempt of filing insider holdings ...
Law360 (June 8, 2020, 3:26 PM EDT) -- Settlement talks are underway in a derivative suit brought by Cocrystal Pharma Inc. shareholders over a $27 million pump-and-dump scheme that purportedly ...
June 26 (Reuters) - Cocrystal Pharma Inc: * COCRYSTAL PHARMA INC - ON JUNE 22, BOARD APPROVED INCREASE IN ANNUAL BASE SALARY OF CEO FROM $200,000 TO $315,000 * COCRYSTAL PHARMA INC - BOARD ...